1. Home
  2. MSGM vs PHIO Comparison

MSGM vs PHIO Comparison

Compare MSGM & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorsport Games Inc.

MSGM

Motorsport Games Inc.

HOLD

Current Price

$4.48

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.24

Market Cap

14.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSGM
PHIO
Founded
2018
2003
Country
United States
United States
Employees
N/A
6
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
14.6M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
MSGM
PHIO
Price
$4.48
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.67
AVG Volume (30 Days)
149.6K
667.1K
Earning Date
06-22-2026
06-17-2026
Dividend Yield
N/A
N/A
EPS Growth
252.13
N/A
EPS
1.43
N/A
Revenue
$741,000.00
N/A
Revenue This Year
$69.07
N/A
Revenue Next Year
$30.56
N/A
P/E Ratio
$3.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.81
52 Week High
$5.78
$4.19

Technical Indicators

Market Signals
Indicator
MSGM
PHIO
Relative Strength Index (RSI) 56.29 55.32
Support Level $2.59 $1.01
Resistance Level $4.57 $1.43
Average True Range (ATR) 0.53 0.08
MACD 0.03 0.01
Stochastic Oscillator 44.12 85.58

Price Performance

Historical Comparison
MSGM
PHIO

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Share on Social Networks: